NC-XILIS-INC
13.7.2022 14:02:12 CEST | Business Wire | Press release
Xilis, Inc., a pioneering biotechnology company developing its MicroOrganoSphere™ (MOS™) technology to guide precision therapy for cancer patients and accelerate drug discovery and development, has closed an extension of over US$19 million to its Series A financing round, bringing the total amount raised to over US$89 million. New investor FPV Ventures led the extension, with participation from fellow new investor Alexandria Venture Investments and existing investors EQT Life Sciences, Mubadala Capital Management, Pear Ventures, GV (formerly Google Ventures), the Duke Angel Network, Catalio Capital Management, Two Sigma Ventures, Felicis Ventures, Alix Ventures and other strategic partners.
“Despite unprecedented market conditions in the biotech sector, we raised this extension at a step-up valuation and from several of the most reputable global investors. Our investors are strongly encouraged by the progress we have made in building diagnostic programs that predict patient response and achieving significant traction in partnered drug discovery and development,” said Xiling Shen, PhD, Founder and Chief Executive Officer of Xilis. “Our MOS technology is the first end-to-end, high-throughput patient-derived model drug discovery platform to identify drug candidates with a high probability of clinical success.”
The company will use the Series A funding to advance its proprietary MOS platform. This innovative MOS technology is the first truly scalable patient-derived model that recapitulates the tumor microenvironment and immune interactions necessary for next-generation immuno-oncology and cell therapy drug discovery. In addition, the MOS platform can be applied in a clinical setting to aid clinicians to make precision oncology treatment decisions, identifying treatments that lead to the best response for each patient.
“Xilis has pushed forward and achieved meaningful scientific breakthroughs that will change the way cancer drugs are being discovered and how patients are being selected to achieve the most optimal response – realizing the goal of personalized precision oncology,” said Wesley Chan, Co-Founder & Managing Partner of FPV Ventures. “With support from a world-class investor consortium, Xilis is set to continue its efforts in clinical diagnostics and accelerate the company’s growth by expanding its MOS technology into biopharma R&D and drug development.”
Recently, the company announced its participation in the Netherlands-based Oncode-PACT Consortium to accelerate the development of cancer drugs and was selected as the cover article/story in the June issue of the journal Cell Stem Cell highlighting its MOS technology and application in precision oncology.
"Xilis' innovative MOS technology can enable unlocking the full potential of patient-derived microtumors by accelerating their use both in the clinic and for drug discovery and development," said John de Koning, Partner at EQT Life Sciences. "Patients will benefit greatly from Xilis’ precision oncology treatment decisions by avoiding time spent on treatment cycles that are ineffective, and instead, receive therapies with the greatest potential of success quickly and efficiently."
About Xilis
Based in Durham, North Carolina, Xilis, Inc. is a biotechnology company developing a precision oncology platform that guides treatment decisions for oncologists to improve cancer care outcomes for patients and enables drug discovery and development with pharmaceutical companies. Xilis’ proprietary MicroOrganoSphere™ (MOS) technology consists of miniature patient tumors that capture the full microenvironment and heterogeneity and provides an automated and scalable solution. Using MOS and AI-driven algorithms, Xilis is developing a Xilis Response Score™ for the clinic, enabling oncologists to make informed and timely treatment decisions. Additionally, the MOS technology is speeding up the discovery and clinical development of new drug candidates.
To learn more about Xilis, visit our website at Xilis.com or follow us on LinkedIn .
About FPV
FPV is a new $450m fund focused on backing and serving mission-driven founders throughout their entire journey. Founded by Wesley Chan (Founder of Google Analytics and Google Voice) and Pegah Ebrahimi (former COO of Morgan Stanley Tech Banking and COO of Cisco Collaboration), the firm has backed well-known, high-impact startups including Canva, Flexport, Guild Education, Xilis, and Manifold Bio.
About EQT Life Sciences
EQT Life Sciences was formed in 2022 following an integration of LSP, a leading European life sciences venture capital firm, into the EQT platform. As LSP, the firm raised over EUR 3.0 billion (USD 3.5 billion) and supported the growth of more than 150 companies since it started to invest over 30 years ago. With a dedicated team of highly experienced investment professionals, coming from backgrounds in medicine, science, business, and finance, EQT Life Sciences backs the smartest inventors who have ideas that could truly make a difference for patients.
The team combines deep sector knowledge, analytical skills, and investment experience to provide the added value that inventors seek. EQT Life Sciences’ broad life sciences and healthcare network is highly complementary to EQT’s global healthcare sector franchise and makes EQT an even better and more innovative healthcare investor. More info: www.eqtgroup.com/lifesciences
View source version on businesswire.com: https://www.businesswire.com/news/home/20220713005121/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vonage Brings Network Innovation to Mobile World Congress 202626.2.2026 09:33:00 CET | Press release
Vonage, part of Ericsson (NASDAQ: ERIC), is set to make an impact at Mobile World Congress (MWC) 2026, the connectivity industry’s most influential exhibition, taking place March 2–5 in Barcelona. Vonage’s presence will include product demos, thought leadership sessions, and ecosystem collaborations, showcasing how the Company is leading the transformation of mobile networks into the enterprise platform of the future. “The digital arena is undergoing a fundamental shift as mobile networks transform into platforms and redefine the enterprise technology stack,” said Neelam Sandhu, Chief Marketing Officer at Vonage. “Mobile World Congress is where possibilities turn into real-world applications, and we demonstrate the capabilities and intelligence embedded in mobile networks to developers and enterprises, showcasing how they are becoming engines of innovation for industries worldwide. I am excited for Vonage to be at the helm of the thought leadership conversation and to reveal our latest
KAYTUS Enhances KSManage with Full-Stack O&M Visibility for AI Data Centers26.2.2026 09:02:00 CET | Press release
KSManage is designed for next-gen AI data center, with four-level visibility across components, servers and cabinets, clusters, and AI jobs, and ensures the AI data centers’ high availability As AI data centers scale to support increasingly complex AI workloads, traditional IT monitoring can no longer provide the visibility required for reliable operations. KAYTUS, a leading provider of end-to-end AI and liquid cooling solutions, has significantly upgraded KSManage, introducing full-stack, four-level visibility across components, servers and cabinets, clusters, and AI jobs, to address the challenges of complex troubleshooting, higher component failure rates, intricate application dependencies and delayed responses to operations and maintenance (O&M) incidents generated by demanding AI data center operations. The enhanced platform enables precise fault localization, faster incident response, and proactive operations. With KSManage, KAYTUS helps customers maximize availability, improve o
NIPPON KINZOKU to Expand Sales of Ultra-Light Magnesium Alloy Foil: Empowering the Future with Eco-Product26.2.2026 09:01:00 CET | Press release
Driving Innovation in XR and Transportation with Unmatched Lightness and Damping Performance NIPPON KINZOKU CO., LTD. (TOKYO: 5491) (Headquarters: Minato-ku, Tokyo) is proud to announce a strategic expansion in the sales of its Magnesium Alloy Foil. Positioned as a core "Eco-Product" that contributes to reducing environmental impact, this high-performance material addresses diverse industrial needs by offering the lightest weight among practical metals combined with exceptional vibration-damping properties. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226621455/en/ Magnesium Alloy Foil (Alloy: AZ31B, Thickness: 0.05 mm, Width: 100 mm) Magnesium alloy is gaining global attention for its incredibly low specific gravity approximately 1/4.5 that of steel and 1/2.5 that of titanium—while maintaining excellent specific strength, stiffness, and damping performance. Target Markets: Beyond mobile PCs and high-end smartphones, we
Mobileum Enables GSMA Industry Services’ Launch of VOLTIS 5G Extension, Streamlining Global 5G Roaming Verification26.2.2026 09:00:00 CET | Press release
New framework reduces bilateral testing complexity and accelerates time-to-market for next-generation roaming services Mobileum Inc. (“Mobileum”), a leading global provider of analytics and network solutions, today announced its expanded role in enabling GSMA Industry Services’ launch of the VOLTIS (Voice over LTE Interoperability & Testing Service) 5G Extension Verification Program. The new extended program goes beyond the existing VoLTE/IMS verification framework to include 5G readiness verification, providing operators with a standardized path to validate next-generation roaming and interoperability. As an appointed verification partner, Mobileum manages the end-to-end validation process, from test planning and resource validation through test execution, troubleshooting, and final reporting, delivering a streamlined, globally recognized verification experience for operators worldwide. As 5G roaming scales globally, operators face increased complexity in validating VoLTE and 5G inter
Lone Star Agrees to Acquire Central London Office Building26.2.2026 08:51:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real Estate Fund VII, L.P. has reached an agreement to acquire 90 Whitfield Street in London, UK from Derwent London. The property, located in central London’s West End sub-market of Fitzrovia, is comprised of 107,000 total square-feet with 99,000 square-feet dedicated to fully developed office space and a retail space on the ground floor of 8,000 square-feet. The building offers highly desirable styling including floor-to-ceiling glazing and generous heights, flexible floor plates, a recently refurbished reception space and large central atrium, and the property’s top floor includes its own privately accessed 900 square-foot rooftop terrace. The asset is also located on an attractive corner position that affronts Tottenham Court Road, one of London’s principal thoroughfares, and is within walking distance of six separate tube stations providing access from across the greater metropolitan area. “We have strong
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom